FLUID THERAPY CHART / JANE QUANDT , DVM, MS, DACVA, DACVECC ///
/// FLUID THERAPY CHART / JANE QUANDT , DVM, MS, DACVA, DACVECC
ADDITIVES
Glucose (g/L)
Na+ (mEq/L)
Cl- (mEq/L)
K+ (mEq/L)
Ca++ (mEq/L)
Buffer (mEq/L) Organic anion
Osmolarity (mOsm/L)
Mg+ (mEq/L)
SID mEq/L
Solution
Cal/L pH
Glucose (g/L)
Na+ (mEq/L)
Cl- (mEq/L)
K+ (mEq/L)
Ca++ (mEq/L)
Buffer (mEq/L)
Osmolarity (mOsm/L)
Cal/L
pH
5% Dextrose
50
0
0
0
0
0
252
170
4
0
0
8.4% NaHCO3
0
1000
0
0
0
1000 Bicarb 2000
0
8
10% Dextrose
100
0
0
0
0
0
505
340
4
0
0
10% CaCl2
0
0
2720
0
1360
0
4080
5.5-7.5
2.5% Dextrose in 0.45% NaCl 5% Dextrose in 0.45% NaCl 5% Dextrose in 0.9% NaCl
25
77
77
0
0
0
280
85
4.5
0
0
14.9% KCL
0
0
2000
2000
0
0
4000
50
77
77
0
0
0
406
170
4
0
50% Dextrose
500
0
0
0
0
0
2780
1700
4.2
50
154
154
0
0
0
560
170
4
0
0.45% KPO4
0
0
0
4400
7400
0.9% NaCl
0
154
154
0
0
0
308
0
5
0
0
Ca gluonate
465
680
6-8
Plasmalyte 148™ or Normosol-R™
Acetate (27) Gluconate (23)
0
140
98
5
0
294-296 0
5.5
3
27-50
COLLOIDS
25% Human Albumin Can have fatal reactions
LRS
0
130
109
4
3
Lactate (28)
272-275
9
6.5
0
27
6% Tet- rastarch
6% Tet- rastarch Hex- tend™
Isotonic crystal- loids
6% Het- arstarch Hespan™
Canine Albumin lyophilized
6% Tetrastarch Tetraspan™
10% Pen- tastarch
6% Pen- tastarch
Whole Blood
2.5% Dextrose in LRS
Properties
FFP
25
130
109
4
3
Lactate (28)
398
85
0
Volu- ven™
5% Dextrose in LRS 50
130
109
4
3
Lactate (28)
524
179
5
0
MW in KD
0
450
280
130
69
LRS + 16 mEq/L KCL 0
129
124
20
3
Lactate (28)
304
0
0
LRS + 2.5% Dextrose + 16 mEq/L KCL LRS + 5% Dextrose + 16 mEq/L KCL
Number Av
0
69
110
69
304
24
123
118
19
3
Lactate (26)
420
94
0
mOsm/L
250-308 300-310 308-326 308
310
308
300
300
296
45
117
113
18
3
Lactate (25)
526
0
COP mmHg
0
26
23-50 31-36 190-200
30-35 31
20
20
40
Plasmalyte 56
0
40
40
13
0
Acetate (16)
110
0
5.5
3
Plasmalyte 56 + 2.5% Dextrose
% vol expansion
20-25 100-200 100-200 130
300-500 1.2 times
50
40
40
16
0
Acetate (12)
406
3
Acetate (27) Gluconate (23) Acetate (24) Malate (5)
Hrs of expansion
1-4
8-26
12-24 2-6
12-24
Plasmalyte-A™
0
140
98
5
0
294
0
7.4
3
27-50
pH
5.5
5
4-5.5
5
5.9
varies
varies
5.6-6.4
Sterofundin-™ Iso 0
145
127
4
5
309
0
5.5-5.9 2
25.5
Na+ mEq/L Cl- mEq/L K+ mEq/L Mg++ mEq/L" Ca++ mEq/L
7.5% NaCl Hypertonic
154
154
154
0
0
154
143
140
140-145 140
0
1283
1283
0
0
0
2567
0
5.5
0
0
154
154
154
0
0
154
124
100
105-110 118
Normosol-M
50
40
40
13
0
Acetate (16)
364
3
0
0
0
0
0
0
3
4
4-5
4
Ringer’s
0
148
156
4
4.5
309
0
6
0
0
0
0
0
0
0
0.9
0
0-1.5
1
NaCL 0.45%
0
77
77
0
0
0
154
0
5.6
0
0
Plasmalyte-56 in 5% dextrose
0
0
2
0
0
0
5
0
0-5
2.5
50
40
40
13
0
Acetate (16)
363
170
3.5-6
3
16
Dextrose g/L
0
0
0
0
0
0
0.99
0-4
0-4
0
References: •
Guideline for potassium supplementation for hypokalemia Patient potassium
DiBartola SP, De Morais HA. Disorders of Potassium in DiBartola SP ed, Fluid Therapy in Small Animal Practice 2nd ed, WB Saunders, 2000, pg 73-107. • DiBartola SP. Introduction to fluid therapy in DiBartola SP ed, Fluid Therapy in Small Animal Practice 2nd ed, WB Saunders, 2000, pg 265-280. • Muir WW. Current Controversies of Fluid Selection: Crystalloids vs. Colloids - What Difference Does it Make? IVECC’s 2016 proceedings, Gapevine, TX. • Rudloff E, Hopper K. Crystalloid and colloid compositions and their impact. Frontiers in Veterinary Science 2021,8: 1-11. • Silverstein DC, Santoro-Beer K. Daily intravenous fluid therapy in Silverstein DC, Hopper K eds Small Animal Critical Care Medicine 2nd ed. Elsevier 2015; 316- 321.
0 Bicarb (24)
Acetate (24) Malate (5)
Rate of potassium supplementation
Organic anion mEq/L
Lactate (28)
0
0
0
0
0
0
Normal to mild hypokalemia > 3.5 mEq/L
0.05 to 0.1 mEq/kg/hr
Moderate hypokalemia 2.5 to 3.5 mEq/L
0.3 mEq/kg/hr
Plasma half-life in hrs 0.5
50
2-12
12
16-24
Severe hypokalemia < 2.5 mEq/L 0.4 to 0.5 mEq/kg/hr do not exceed 0.4 to 0.5 mEq/kg/hr do not exceed this rate!
SID mEq/L
0
0
0
0
28
12
© VETgirl 2021. Every effort has been made to offer the most current, correct, and clearly expressed information possible. Nevertheless, inadvertent errors in information may occur. In particular but without limiting anything here, VETgirl disclaims any responsibility for typographical errors and accuracy of the information that may be contained on this resource. VETgirl also reserves the right to make changes at any time without notice. VETgirl makes no warranties or representations whatsoever regarding the quality, content, completeness, or adequacy of such information and data. In any situation where the official printed publications of VETgirl differ from the text contained in this system, the official printed documents take precedence.
Made with FlippingBook - Online Brochure Maker